PHARMENA - stock earnings
PHR.WA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -473000 PLN | 9.7 million PLN |
| 2023Q3 | 30.1 million PLN | 5000 PLN |
| 2023Q2 | -570000 PLN | -4.6 million PLN |
| 2023Q1 | -155000 PLN | 4.7 million PLN |
| 2022Q4 | -827000 PLN | 6.2 million PLN |
| 2022Q3 | -110000 PLN | 4.6 million PLN |
| 2022Q2 | -462000 PLN | 4.7 million PLN |
| 2022Q1 | -171000 PLN | 3.6 million PLN |
| 2021Q4 | -1.5 million PLN | 4.4 million PLN |
| 2021Q3 | -595000 PLN | 4.0 million PLN |
| 2021Q2 | -1.9 million PLN | 3.5 million PLN |
| 2021Q1 | -568000 PLN | 3.3 million PLN |
| 2020Q4 | -3.5 million PLN | 2.5 million PLN |
| 2020Q3 | -746000 PLN | 3.0 million PLN |
| 2020Q2 | -1.6 million PLN | 1.8 million PLN |
| 2020Q1 | -1.1 million PLN | 2.5 million PLN |
| 2019Q4 | -2.4 million PLN | 2.4 million PLN |
| 2019Q3 | -1.1 million PLN | 3.4 million PLN |
PHR.WA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 28.9 million PLN | 9.8 million PLN |
| 2022 | -1.6 million PLN | 19.0 million PLN |
| 2021 | -4.6 million PLN | 15.2 million PLN |
| 2020 | -6.9 million PLN | 9.9 million PLN |
| 2019 | -9.4 million PLN | 11.1 million PLN |
| 2018 | -444000 PLN | 13.0 million PLN |
| 2017 | -2.5 million PLN | 12.5 million PLN |
| 2016 | -1.7 million PLN | 15.9 million PLN |
| 2015 | -3.6 million PLN | 17.5 million PLN |
PHR.WA
Price: PLN6.50
52 week price:
Earnings Per Share: 2.60 PLN
P/E Ratio: 2.41
Exchange: WSE
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 69.7 million
Average Dividend Frequency: 1